Inventor · disambiguated record
Shilong Fu
Also filed as: FU SHILONG
7 granted patents·3 pending applications·11 citations·filing 2015–2021
77Inventor score
Top patents by PatentIndex Score
10 records- 0187US11357826B2IL-10 EGFR antibody fusion protein and uses thereofDINGFU BIOTARGET CO LTD·Filed 2019·Granted Jun 14, 2022·4 cites·4 claims
- 0278US10471124B2Proteinaceous heterodimer and use thereofDINGFU BIOTARGET CO LTD·Filed 2015·Granted Nov 12, 2019·3 cites·3 claims
- 0375US11987609B2Proteinaceous heterodimer and use thereofDINGFU BIOTARGET CO LTD·Filed 2018·Granted May 21, 2024·1 cites·2 claims
- 0469US12252542B2Anti-CD137 antibodies and method of treating colorectal cancer using themSHIHUIDA PHARMACEUTICAL GROUP JILIN CO LTD·Filed 2019·Granted Mar 18, 2025·1 cites·20 claims
- 0565US10875926B2Fully human antibody against human CD 137DINGFU BIOTARGET CO LTD·Filed 2015·Granted Dec 29, 2020·1 cites·13 claims
- 0665US10624974B2Anti-OX40 antibody and application thereofDINGFU BIOTARGET CO LTD·Filed 2015·Granted Apr 21, 2020·1 cites·6 claims
- 0754US2023241236A1Methods and compositions for cancer treatmentDINGFU BIOTARGET CO LTD·Filed 2021·Application pending·0 cites
- 0850US2022356259A1Isolated antigen-binding protein and application thereofDINGFU BIOTARGET CO LTD·Filed 2020·Application pending·0 cites
- 0948US11883503B2Methods and compositions for cancer treatmentDINGFU BIOTARGET CO LTD·Filed 2018·Granted Jan 30, 2024·0 cites·5 claims
- 1048US2022227827A1Proteinaceous heterodimer and use thereofDINGFU BIOTARGET CO LTD·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →